Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F23%3A00083825" target="_blank" >RIV/00023001:_____/23:00083825 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/60076658:12110/23:43905766

Výsledek na webu

<a href="https://academic.oup.com/europace/article/25/1/185/6763073" target="_blank" >https://academic.oup.com/europace/article/25/1/185/6763073</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1093/europace/euac144" target="_blank" >10.1093/europace/euac144</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper

Popis výsledku v původním jazyce

Atrial fibrillation (AF) is the most common clinical arrhythmia with substantial health and socioeconomic impact on healthcare. The number of people affected by this condition was estimated to be 33.5 million in 2010, with an increasing prevalence and incidence over the coming years. In 2017, there were 37.6 million [95% confidence interval (CI): 32.5–42.6 million] individuals with AF/atrial flutter globally. The estimated number of subjects with AF in 2030 in Europe will be 14–17 million, and the number of new cases of AF per year at 120 000–215 000. Atrial fibrillation is independently associated with increased mortality and morbidity from complications such as ischaemic stroke, dementia, and cognitive dysfunction. Oral anticoagulation can significantly reduce the risk of stroke, dementia, and death. As a part of a holistic or integrated approach to AF care, it is associated with improved outcomes and is advocated in guidelines.

Název v anglickém jazyce

Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper

Popis výsledku anglicky

Atrial fibrillation (AF) is the most common clinical arrhythmia with substantial health and socioeconomic impact on healthcare. The number of people affected by this condition was estimated to be 33.5 million in 2010, with an increasing prevalence and incidence over the coming years. In 2017, there were 37.6 million [95% confidence interval (CI): 32.5–42.6 million] individuals with AF/atrial flutter globally. The estimated number of subjects with AF in 2030 in Europe will be 14–17 million, and the number of new cases of AF per year at 120 000–215 000. Atrial fibrillation is independently associated with increased mortality and morbidity from complications such as ischaemic stroke, dementia, and cognitive dysfunction. Oral anticoagulation can significantly reduce the risk of stroke, dementia, and death. As a part of a holistic or integrated approach to AF care, it is associated with improved outcomes and is advocated in guidelines.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Europace

ISSN

1099-5129

e-ISSN

1532-2092

Svazek periodika

25

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

14

Strana od-do

185-198

Kód UT WoS článku

000869325300001

EID výsledku v databázi Scopus

2-s2.0-85143056837